Follow
Mark Behlke
Mark Behlke
Integrated DNA Technologies
Verified email at idtdna.com
Title
Cited by
Cited by
Year
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
DH Kim, MA Behlke, SD Rose, MS Chang, S Choi, JJ Rossi
Nature biotechnology 23 (2), 222-226, 2005
12642005
Identification of preexisting adaptive immunity to Cas9 proteins in humans
CT Charlesworth, PS Deshpande, DP Dever, J Camarena, VT Lemgart, ...
Nature medicine 25 (2), 249-254, 2019
9852019
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
CA Vakulskas, DP Dever, GR Rettig, R Turk, AM Jacobi, MA Collingwood, ...
Nature medicine 24 (8), 1216-1224, 2018
7592018
Progress towards in vivo use of siRNAs
MA Behlke
Molecular Therapy 13 (4), 644-670, 2006
7432006
Chemical Modification of siRNAs for In Vivo Use
MA Behlke
Oligonucleotides 18 (4), 305-320, 2008
6292008
Functional polarity is introduced by Dicer processing of short substrate RNAs
SD Rose, DH Kim, M Amarzguioui, JD Heidel, MA Collingwood, ME Davis, ...
Nucleic acids research 33 (13), 4140-4156, 2005
5362005
Chemical modification and design of anti-miRNA oligonucleotides
KA Lennox, MA Behlke
Gene therapy 18 (12), 1111-1120, 2011
5282011
A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells
JT Marques, T Devosse, D Wang, M Zamanian-Daryoush, P Serbinowski, ...
Nature biotechnology 24 (5), 559-565, 2006
5182006
Analysis of microRNA turnover in mammalian cells following Dicer1 ablation
MP Gantier, CE McCoy, I Rusinova, D Saulep, D Wang, D Xu, AT Irving, ...
Nucleic acids research 39 (13), 5692-5703, 2011
5082011
Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins
RM Quadros, H Miura, DW Harms, H Akatsuka, T Sato, T Aida, R Redder, ...
Genome biology 18, 1-15, 2017
4662017
Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
KA Lennox, MA Behlke
Nucleic acids research 44 (2), 863-877, 2016
4482016
Effects of sodium ions on DNA duplex oligomers: improved predictions of melting temperatures
R Owczarzy, Y You, BG Moreira, JA Manthey, L Huang, MA Behlke, ...
Biochemistry 43 (12), 3537-3554, 2004
4402004
Predicting stability of DNA duplexes in solutions containing magnesium and monovalent cations
R Owczarzy, BG Moreira, Y You, MA Behlke, JA Walder
Biochemistry 47 (19), 5336-5353, 2008
4272008
Murine T-cell receptor mutants with deletions of beta-chain variable region genes.
MA Behlke, HS Chou, K Huppi, DY Loh
Proceedings of the National Academy of Sciences 83 (3), 767-771, 1986
4211986
Design of LNA probes that improve mismatch discrimination
Y You, BG Moreira, MA Behlke, R Owczarzy
Nucleic acids research 34 (8), e60-e60, 2006
3892006
Hybridization kinetics and thermodynamics of molecular beacons
A Tsourkas, MA Behlke, SD Rose, G Bao
Nucleic acids research 31 (4), 1319-1330, 2003
3822003
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
D Rosenblum, A Gutkin, R Kedmi, S Ramishetti, N Veiga, AM Jacobi, ...
Science advances 6 (47), eabc9450, 2020
3732020
miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors
T Melkman‐Zehavi, R Oren, S Kredo‐Russo, T Shapira, AD Mandelbaum, ...
The EMBO journal 30 (5), 835-845, 2011
3472011
Chitosan/siRNA nanoparticle–mediated TNF-α knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model
KA Howard, SR Paludan, MA Behlke, F Besenbacher, B Deleuran, ...
Molecular therapy 17 (1), 162-168, 2009
3462009
Progress toward in vivo use of siRNAs-II
GR Rettig, MA Behlke
Molecular therapy 20 (3), 483-512, 2012
2782012
The system can't perform the operation now. Try again later.
Articles 1–20